
|Videos|June 28, 2017
Could SBRT Have Role in Metastatic Kidney Cancer?
Author(s)Thomas Schwaab, MD, PhD
This video examines a pilot trial that tested stereotactic body radiotherapy plus nephrectomy in patients with renal cell carcinoma.
Advertisement
In this video, Thomas Schwaab, MD, PhD, of Roswell Park Cancer Institute in Buffalo, New York, discusses a pilot trial that tested stereotactic body radiotherapy (SBRT) plus nephrectomy in patients with renal cell carcinoma.
The
Video courtesy of
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy
2
3 Things You Should Know About TROP2-Directed Antibody-Drug Conjugates in the Frontline Treatment of Metastatic Triple-Negative Breast Cancer
3
Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review
4
This Week in Oncology: Real-World NSCLC Care and AACR 2026 Updates
5
























































